Trials / Completed
CompletedNCT01216605
Oxytocin and Emotion Recognition
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- University Hospital Freiburg · Academic / Other
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The present study was designed to investigate the effects of a single dose of synthetic oxytocin on facial emotion recognition in healthy adult man. Pictures of emotional faces are presented very briefly for a few milliseconds in a backward-masking paradigm in order to vary the level of awareness. In a randomized placebo-controlled between-subject design, recognition performance is compared between a drug (24 IU oxytocin) and a placebo condition. We hypothesize that oxytocin enhances emotion recognition even for facial stimuli processed with limited awareness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Syntocinon 24 IU | |
| DRUG | Placebo |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2010-10-07
- Last updated
- 2010-10-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01216605. Inclusion in this directory is not an endorsement.